## Empirical Antibiotic Therapy in Neonatal Sepsis (Age 0–7 Days) **Key Point:** The choice of empirical antibiotics in early-onset neonatal sepsis (EOS, <72 hours) depends on risk factors and the need to cover *Gram-positive cocci* (Group B Streptococcus, *Listeria monocytogenes*) and *Gram-negative enteric organisms* (*E. coli*, *Klebsiella*). ### Standard Regimens by Clinical Scenario | Scenario | First-Line Regimen | Rationale | | --- | --- | --- | | **EOS without meningitis** | Ampicillin + Gentamicin | Covers GBS, *Listeria*, and Gram-negative bacilli | | **EOS with suspected meningitis** | Ampicillin + Cefotaxime (NOT ceftriaxone) | Cefotaxime achieves better CSF penetration; ceftriaxone is NOT recommended in neonates <7 days | | **Cephalosporin monotherapy** | NOT recommended for EOS | Does not reliably cover *Listeria monocytogenes* | **High-Yield:** Ceftriaxone is **contraindicated in neonates <7 days** because: 1. It displaces bilirubin from albumin, increasing risk of kernicterus. 2. It does not cover *Listeria monocytogenes*. 3. Cefotaxime is the preferred third-generation cephalosporin in this age group. **Clinical Pearl:** Even if the neonate appears to have only bacteremia (no meningitis), ampicillin + gentamicin is preferred over cephalosporin monotherapy because *Listeria* coverage is essential and cannot be assumed from culture results at the time of empirical therapy initiation. ### Duration of Therapy Once culture is positive: - **GBS or *E. coli* (without meningitis):** 7–10 days IV antibiotics. - **Meningitis:** 14–21 days depending on organism. - **Negative cultures but clinical sepsis:** 7–10 days is standard. **Why Option 1 (Ceftriaxone monotherapy) is WRONG:** - Ceftriaxone is contraindicated in neonates <7 days of age. - It does not cover *Listeria monocytogenes*. - It increases bilirubin displacement risk (kernicterus). - Cefotaxime is the correct third-generation cephalosporin choice if meningitis is suspected.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.